» News

Scholarships for Tennis Players with Diabetes

February 17, 2005 10:43 PM

NOVO NORDISK DONNELLY AWARDS PROVIDE TWO SCHOLARSHIPS

Novo Nordisk, the leading pharmaceutical company in diabetes care, is proud to be the new sponsor of the Novo Nordisk Donnelly Awards. Billie Jean King established the awards in 1998 to encourage diabetic children to lead an active life and compete in tennis. The two awards each provide $5,000 scholarships to young tennis players suffering from diabetes. The award is named after two long-time World Team Tennis executives and tennis champions, Diane Donnelly Stone and Tracy Donnelly Maltby, who are sisters. Stone was an All-American and NCAA doubles champion at Northwestern University, and Maltby earned All-Big Ten honors at the University of Iowa. Both women have had diabetes since childhood.

Two young people, ages 14-21, who have diabetes and play tennis competitively in tournaments or on their school team will receive a $5,000 scholarship. In addition, the recipients will travel to Philadelphia to receive their awards at a World Team Tennis match in July, 2005. All applications must be received by June 1, 2005, and the winners will be announced by July 1, 2005. For more information and to download an application log on to www.wtt.com and click on BJK/WTT Charities.

The winners for 2004 are Mitch Fender, 18, of Fernandina Beach, Florida, and Travis Fillmore of  Tahlequah, Oklahoma.  Fender was captain of  his high school tennis and golf teams, and was an honor student despite having to give himself insulin injections three times per day.  Fillmore wears an insulin pump to control his diabetes. He is ranked #47 in the nation in the 14-and-under age division, is an honor student, and has won awards in both art and science competitions. 

Novo Nordisk is a health care company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women.

For further information contact:

Anne Guerrant, Executive Director  
Billie Jean King WTT Charities, Inc
aguerrant@wtt.com  or
Jeff Harrison
jharrison@wtt.com

 

Back

 
 

 
 
 
 
 
Close